STME (Stimcell Energetics) Net Current Asset Value: $-0.08 (As of Feb. 2026)


STME Stimcell Energetics Inc STME
25 GF Score
Price $0.31
! 4 Warning Signs
View Full Analysis

What is Stimcell Energetics Net Current Asset Value?

Stimcell Energetics STME 25 Net Current Asset Value is $-0.08 as of Feb. 2026. GuruFocus rates STME with a GF Score™ of 25/100. The stock has 4 warning signs investors should review. Among 566 Medical Devices & Instruments companies, Stimcell Energetics ranks worse than 176678.27% on this metric.

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Stimcell Energetics's net current asset value per share for the quarter that ended in Feb. 2026 was $-0.08.

The historical rank and industry rank for Stimcell Energetics's Net Current Asset Value or its related term are showing as below:

STME's Price-to-Net-Current-Asset-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 5.05
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

Stimcell Energetics  (OTCPK:STME) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Stimcell Energetics Net Current Asset Value Related Terms


Stimcell Energetics Net Current Asset Value Historical Data

* Premium members only.

The historical data trend for Stimcell Energetics's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stimcell Energetics Net Current Asset Value Chart

Stimcell Energetics Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.38 -0.48 -0.57 -0.04 -0.06

Stimcell Energetics Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 -0.06 -0.07 -0.07 -0.08

STME vs NVNO, TRIB, AIDX: Net Current Asset Value Comparison

For the Medical Devices subindustry, Stimcell Energetics's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stimcell Energetics Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stimcell Energetics's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Stimcell Energetics's Price-to-Net-Current-Asset-Value falls into.


STME
25GF Score
Stimcell Energetics Inc STME
Net Current Asset Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stimcell Energetics Net Current Asset Value Calculation

Stimcell Energetics's Net Current Asset Value (NCAV) per share for the fiscal year that ended in May. 2025 is calculated as

Net Current Asset Value Per Share(A: May. 2025 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(0.021-1.268-0-0)/20.141
=-0.06

Stimcell Energetics's Net Current Asset Value (NCAV) per share for the quarter that ended in Feb. 2026 is calculated as

Net Current Asset Value Per Share(Q: Feb. 2026 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(0.035-1.713-0-0)/20.891
=-0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Current Asset Value of $-0.08 mean?
Stimcell Energetics (STME) has a Net Current Asset Value of $-0.08 as of Feb. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Stimcell Energetics and its competitors. According to the industry distribution chart, Stimcell Energetics ranks #999999 out of 566 companies in the Medical Devices & Instruments industry.
Is Stimcell Energetics' Net Current Asset Value too high?
Stimcell Energetics' current Net Current Asset Value is $-0.08. Based on the distribution chart, Stimcell Energetics ranks #999999 out of 566 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Stimcell Energetics has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Stimcell Energetics' Net Current Asset Value compare to NVNO and TRIB?
According to the Medical Devices & Instruments industry distribution chart, Stimcell Energetics ranks #999999 out of 566 companies for Net Current Asset Value. This places Stimcell Energetics in the lower half of its industry. The industry median Net Current Asset Value is 5.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 5.05, based on 566 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Stimcell Energetics and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 5.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stimcell Energetics's current Net Current Asset Value is $-0.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stimcell Energetics stock overvalued right now?
Stimcell Energetics (STME) has a current Net Current Asset Value of $-0.08. The current Net Current Asset Value is $-0.08. Stimcell Energetics' overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Stimcell Energetics (STME), the current Net Current Asset Value is $-0.08 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Stimcell Energetics Business Description

Address 1130 Pender Street, West, Suite 820, Vancouver, BC, CAN, V6E 4A4
Stimcell Energetics Inc is a biotech company focused on the discovery, development, and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness, and alleviate health complications, including, but not limited to: aging, diabetes, high blood pressure, neuropathy, and kidney function. The company's main focus is on continued research and development of its eBalance Technology and its eBalance Home System.
25GF Score

Get the complete analysis for STME

Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.31
Price